ETA and AT1 Antagonism in ANCA-vasculitis (SPARVASC)

Clinical trial NCT05630612 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05630612
Sponsor: University of Edinburgh
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

ANCA Associated Vasculitis Cardiovascular Diseases Kidney Diseases

Start date: 2022-12-08
Primary completion: 2024-07-18
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.